The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry Jakub Gregor; Yochai Adir; Martina ¿terclová; Nesrin Mogulkoc; Mordechai R. Kramer; Martina Doubková; Martina Pla¿ková; Veronika Müller; Michael Studnicka; Monika ¿urková; Ladislav Lacina; Katarzyna Lewandowska; Vladimír Barto¿; Petra Ovesná; Ond¿ej Májek; Martina Koziar Va¿áková;

Reduction in Hospital Admissions for Asthma and COPD During the First Year of COVID-19 Pandemic in Spain Marta Galán-Negrillo; Eduardo García-Pachón;

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary Alvar Agustí; Bartolome R. Celli; Gerard J. Criner; David Halpin; Antonio Anzueto; Peter Barnes; Jean Bourbeau; MeiLan K. Han; Fernando J. Martinez; Maria Montes de Oca; Kevin Mortimer; Alberto Papi; Ian Pavord; Nicolas Roche; Sundeep Salvi; Don D. Sin; Dave Singh; Robert Stockley; M. Victorina López Varela; Jadwiga A. Wedzicha; Claus F. Vogelmeier;